The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia

[1] Sanders JE(2011)Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia Blood. 118 1421-8

[2] Woolfrey AE(2002)Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin Ann Hematol. 81 627-31

[3] Carpenter PA(1996)Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood. 87 3045-52

[4] Storer BE(2012)Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence Bone Marrow Transplant. 47 271-6

[5] Hoffmeister PA(2004)Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection Bone Marrow Transplant. 33 9-13

[6] Deeg HJ(2011)NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl 17 1725-38

[7] Kröger N(2015)Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study J Cancer Res Clin Oncol. 141 135-42

[8] Zabelina T(2015)Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan Br J Haematol. 170 719-26

[9] Renges H(2000)Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide Bone Marrow Transplant. 25 1087-92

[10] Krüger W(1991)Gonadal function after allogenic bone marrow transplantation for thalassaemia Arch Dis Child. 66 517-20

[1] Sanders JE(2011)Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia Blood. 118 1421-8

[2] Woolfrey AE(2002)Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin Ann Hematol. 81 627-31

[3] Carpenter PA(1996)Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood. 87 3045-52

[4] Storer BE(2012)Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence Bone Marrow Transplant. 47 271-6

[5] Hoffmeister PA(2004)Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection Bone Marrow Transplant. 33 9-13

[6] Deeg HJ(2011)NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl 17 1725-38

[7] Kröger N(2015)Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study J Cancer Res Clin Oncol. 141 135-42

[8] Zabelina T(2015)Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan Br J Haematol. 170 719-26

[9] Renges H(2000)Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide Bone Marrow Transplant. 25 1087-92

[10] Krüger W(1991)Gonadal function after allogenic bone marrow transplantation for thalassaemia Arch Dis Child. 66 517-20